Stegmaier K - Search Results

1

Golub TR, McLean T, Stegmaier K, Carroll M, Tomasson M, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Biochim Biophys Acta. 1996 Aug 8;1288(1):M7-10. doi: 10.1016/0304-419x(96)00015-7. Biochim Biophys Acta. 1996. PMID: 8764840 Review. No abstract available.

2

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

Shulman DS, Merriam P, Choy E, Guenther LM, Cavanaugh KL, Kao PC, Posner A, Bhushan K, Fairchild G, Barker E, Klega K, Stegmaier K, Crompton BD, London WB, DuBois SG. Shulman DS, et al. Among authors: stegmaier k. Cancer Med. 2023 Jul;12(14):15207-15216. doi: 10.1002/cam4.6208. Epub 2023 Jun 12. Cancer Med. 2023. PMID: 37306107 Free PMC article. Clinical Trial.

3

Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood.

Stegmaier K, Pendse S, Barker GF, Bray-Ward P, Ward DC, Montgomery KT, Krauter KS, Reynolds C, Sklar J, Donnelly M, et al. Stegmaier K, et al. Blood. 1995 Jul 1;86(1):38-44. Blood. 1995. PMID: 7795247 Free article.

4

Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Curr Top Microbiol Immunol. 1996;211:279-88. doi: 10.1007/978-3-642-85232-9_28. Curr Top Microbiol Immunol. 1996. PMID: 8585959 Review. No abstract available.

5

Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.

Stegmaier K, Takeuchi S, Golub TR, Bohlander SK, Bartram CR, Koeffler HP. Stegmaier K, et al. Cancer Res. 1996 Mar 15;56(6):1413-7. Cancer Res. 1996. PMID: 8640833

6

TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.

McLean TW, Ringold S, Neuberg D, Stegmaier K, Tantravahi R, Ritz J, Koeffler HP, Takeuchi S, Janssen JW, Seriu T, Bartram CR, Sallan SE, Gilliland DG, Golub TR. McLean TW, et al. Among authors: stegmaier k. Blood. 1996 Dec 1;88(11):4252-8. Blood. 1996. PMID: 8943861 Free article.

7

The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG. Golub TR, et al. Among authors: stegmaier k. Curr Top Microbiol Immunol. 1997;220:67-79. doi: 10.1007/978-3-642-60479-9_5. Curr Top Microbiol Immunol. 1997. PMID: 9103676 Review. No abstract available.

8

Gene expression-based high-throughput screening(GE-HTS) and application to leukemia differentiation.

Stegmaier K, Ross KN, Colavito SA, O'Malley S, Stockwell BR, Golub TR. Stegmaier K, et al. Nat Genet. 2004 Mar;36(3):257-63. doi: 10.1038/ng1305. Epub 2004 Feb 8. Nat Genet. 2004. PMID: 14770183

9

Gefitinib induces myeloid differentiation of acute myeloid leukemia.

Stegmaier K, Corsello SM, Ross KN, Wong JS, Deangelo DJ, Golub TR. Stegmaier K, et al. Blood. 2005 Oct 15;106(8):2841-8. doi: 10.1182/blood-2005-02-0488. Epub 2005 Jul 5. Blood. 2005. PMID: 15998836 Free PMC article.

10

A method for high-throughput gene expression signature analysis.

Peck D, Crawford ED, Ross KN, Stegmaier K, Golub TR, Lamb J. Peck D, et al. Among authors: stegmaier k. Genome Biol. 2006;7(7):R61. doi: 10.1186/gb-2006-7-7-r61. Genome Biol. 2006. PMID: 16859521 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters